Skip to content

Clinical trials

Major Depressive Disorder trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: Mexico Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20065
20072
20083
20092
20102
20115
20122
20132
20164
20181
20191
20202
20214
20244
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Unknown status6
Terminated5
Recruiting4
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
H. Lundbeck A/S5
Sanofi5
Janssen Research & Development, LLC3
Pfizer3
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente2
Shire2
Universidad Nacional Autonoma de Mexico2
AstraZeneca1
Dr. Julian Reyes López1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder43
Depressive Disorder5
Mood Disorders3
Anxiety Disorders2
Cognitive Dysfunction2
Anhedonia1
COVID-191
Generalized Anxiety Disorder1
Lethargy1
Mental Disorders1

Trials

Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.